Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03783403
Title A Study of CC-95251, a Monoclonal Antibody Directed Against SIRP?, With Cetuximab in Subjects With Advanced Solid Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications

Advanced Solid Tumor

Therapies

CC-95251

CC-95251 + Cetuximab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN


No variant requirements are available.